We designed multiple Small Cluster Oligosaccharide Mimetics (SCOMs) -potential glycosidase inhibitors -to be metabolically stable and small enough to enter cells or bacteria. Therefore, minimal scaffolds (urea, amide, ammonia) or simply non-glycosidic linkages of carbohydrate structures were central to our synthetic strategy, including: (a) coupling of several natural carbohydrate precursors; (b) total syntheses of aminomethyl tetrahydropyrans and their chiral amides with quinic acid; (c) glycopyranosyl cyanide reduction to prepare crowded clusters on a urea scaffold; (d) total syntheses via cycloadditions leading to amide-linked C-glycosides; (e) reduction of nitromethyl C-glycosides; and (f) a synthesis of hydroxylated 1,2-cyclohexanedicarboxylic acids.
Introduction
After the early years of carbohydrate chemistry around 1900 and Emil Fischer's structure proof of the carbohydrates, this area of chemistry received only little attention. However, carbohydrate chemistry witnessed a renaissance during the 1960's with the advent of the aminoglycoside antibiotics. [1] [2] [3] Synthetic efforts since then have resulted in numerous structural modifications for carbohydrates. Exchange of aglycons on the anomeric carbon, exchange of the glycosidic atom (N-, C-, S-glycosides), exchange of ring substitutents, exchange of the endocyclic heteroatom (carba-, aza-, thia-derivatives), and concise streochemical transformations. Oligosaccharides are now recognized to have functions influencing the entire spectrum of cell activities. Glycolipids and glycoproteins on the cell surface are now known to determine cell-cell interactions with invading bacteria, viruses, and cancer cells. [4] [5] [6] [7] Carbohydrates play central roles in posttranslational modifications of proteins, [8] [9] [10] cell-cell communication, 11 and immune response to pathogens. 10, [12] [13] [14] Aberrations in glycosylation have been linked to severe pathological symptoms. Monosaccharide units combine to oligosaccharides in an almost infinite number of permutations, determined by the stereochemical identity of the linked monosaccharides (e.g. glucose, galactose, mannose), their glycosidic linkage position (e.g. 1→4, 1→6), their anomericity (α or β), and the overall degree of branching. This complexity, further increased by additional modifications such as sulfation or sialation, was suggested recently to serve the evolutionary purpose of "herd immunity". 15, 16 It has become clear over the past three decades that glycosylation is critically important to many of the signaling pathways that turn a normal cell into a cancer cell. Compounds that inhibit specific glycosylation reactions may potentially block the pathways in carcinogenesis. Carbohydrates have been recognized as novel cancer prevention agents. 17 However, a distinct disadvantage of naturally occurring carbohydrates, e. g. O-glycosidically-linked oligosaccharides, is their metabolic instability in biological systems. Therefore, much effort has been spent in the past two decades on the development of feasible pathways towards carbohydrate mimetics, including C-glycosidic sugars, [18] [19] [20] [21] which may compete with their O-glycosidic counterparts in cell surface adhesion, inhibit carbohydrateprocessing enzymes, and interfere in the biosynthesis of specific cell surface carbohydrates. [21] [22] [23] Therefore, carbohydrate mimetics are potential therapeutic agents against HIV and other infections, against cancer, diabetes and other metabolic diseases. [18] [19] [20] [21] [22] [23] Oligosaccharide "clusters" exhibit greatly increased binding constants compared to monosaccharides (cluster effect). [24] [25] [26] [27] [28] [29] Potential targets for medical applications of these clusters have been identified. 30 However, most synthesized glycosidic cluster compounds are too large to permeate cell walls or membranes, and only target cell surface receptors. [24] [25] [26] [27] [28] [29] Therefore, we devoted our work to the synthesis of a variety of Small Cluster Oligosaccharide Mimetics (SCOMs) 31, 32 with enhanced metabolic stability, which presumably may enter the cytosol and internal cell substructures to address internal receptors. Derivatives of shikimic acid have been used to inhibit other biochemical pathways for example the infectious pathway of the influenza virus (common flu). [42] [43] [44] Potent anti-influenza A+B effect has been observed for derivatives of shikimic acid inhibiting viral neuraminidase. The widely-prescribed anti-flu medication Tamiflu TM (Roche, 4, Figure 1 ) is not only effective in treating common flu strains, but it has also been used successfully in the treatment of the bird (avian) flu in laboratory animals. Contrary to animal experiments, Tamiflu's TM effectiveness in humans infected with the H5N1 flu strain is still controversial because only a few studies with limited statistical value have been conducted, and the understanding of the drug's action against the virus is only rudimentary. Tamiflu TM acts as influenza virus neuraminidase inhibitor with the possibility of alteration of virus particle aggregation and release. The less well-known Relenza TM (Zanamivir, GlaxoSmithKline, 5, Figure 1 ) 42 is also an effective inhibitor of common flu strains by the same mechanism. The problem of a sufficient supply of these two drugs in case of an influenza pandemic and the necessity for a continuous search for new structural analogs has been discussed in the literature. 45, 46 For the construction of SCOMs from quinic acid, we used 2-amino-2-deoxy sugars as nucleophiles and quinic lactone as an electrophile (Scheme 1). [47] [48] [49] Starting with 2-acetamido-2-deoxy-D-glucopyranose (6), we prepared the corresponding benzyl glucoside (7) through acidcatalyzed acetal formation. Under these conditions, compound 7 was obtained as a mixture of anomers, which was difficult to separate or crystallize. However, the α-and β-anomer can be obtained clean after per-O-acetylation, recrystallization, and MeO -/MeOH deprotection at room temperature. 50 Compound 7 was then converted to the 4,6-O-benzylidene derivative 8 with benzaldehyde and anhydrous ZnCl 2 followed by removal of the N-acetyl group in ethanolic KOH at reflux to yield 2-amino-4,6-O-benzylidene-2-deoxy-α/β-D-glucopyranose (9) . In parallel, D-(-)-quininc acid was converted to the 4,5-O-isopropylidenated lactone (11), 51 which served as an electrophile in the subsequent acylation of the separated α-and β-anomers 9a/b into the potential disaccharide mimic precursors 12a/b, respectively. We also prepared compounds 21 and 22 as regio-and diastereochemical analogs of 12, respectively. The two corresponding aminoglycosides were synthesized from D-glucose (14). 52 Benzylation followed by 4,6-O-benzylidenation gave compound 16 whose 2-and 3-hydroxyl groups were subsequently mesylated to afford compound 17. Upon treatment of 17 with methoxide, we were able to obtain benzyl-2,3-anhydro-4,6-O-benzylidene-α-D-allopyranoside (18) . The epoxide was surprisingly stable but could be opened with NH 3 under pressure and elevated temperature. The major product (20) with D-altro-configuration was obtained through diaxial opening (Fuerst-Plattner rule) whereas the regioisomer (19) with D-gluco-configuration was only isolated in small quantities from the same reaction. When these products were combined with quinic lactone 11, SCOMs 21 and 22 were obtained, respectively.
Interestingly, the quinic amide ring in all quinamides described above had a predominant twist-boat conformation as determined by NMR in CDCl 3 (Scheme 1). 47, 48 This was confirmed by small gauche 3 J-values and NOEs between H3/H2a/H2b and between H5/H6a/H6b, as well as a significant 4 J between H4 and H2b (W-coupling). We observed the same conformation for the unsubstituted quinamide 13 that was obtained from 11 in a saturated methanolic solution of NH 3 at room temperature. This benzylamide derivative had been described by us earlier; however, without detailed conformational analysis (Scheme 1). 49 The twist-boat conformation is pretty common for the pyranoses/tetrahydropyranes fused to five-membered acetal ring(s) (e.g. see Section 4.1), but is very rare for cyclohexane derivatives. Quinic lactone 11 was also used for acylation of synthesized aminomethyl-Cdideoxyglycopyranosides (Section 7). [47] [48] [49] The molecular models represent 0K structures obtained from molecular dynamics simulation (AM1) with temperature annealing. 
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Dimerization of per-O-acetylated D-glucal was described first by Ferrier and Prasad. 65 In a similar fashion we synthesized products with directly C-linked cycles (Scheme 2) Such compounds may potentially show altered and/or enhanced bioactivity due to a welldocumented cluster effect. [24] [25] [26] [27] [28] [29] The non-physiological nature of the new C-C-linkages in our compounds may transfer metabolic stability also to O-glycosidic bonds still present in their structures. Dimerizations of disaccharidic glycals to tetramers required careful optimization of conditions to minimize cleavage of the disaccharidic bonds by the BF 3 -catalyst. The structural assignment of glycal dimers was based upon NMR data. The original assignment for tri-O-acetyl-D-glucal dimer 31 65 was confirmed by our data, 64, 66 and finally proved by X-ray crystal structure analysis ( Figure 3 ).
66
Figure 3. Molecular structure of compound 31.
The structural analysis of 31 revealed a high degree of rigidity in the molecule. Comparative analysis of the NMR and X-ray data 62, 64, 66 shows that there is virtually no difference between the solution and crystal conformations of both rings in compound 31. The average position of the two ring planes in 31 may be considered nearly perpendicular. The conformational equilibrium for both rings appears to be strongly biased. An absence of a solvent dependence for spin-spin coupling constants also supports these conclusions. The results of this work combined with literature data allowed us to suggest a set of "standard" coupling constants for use in structural analysis of 2,3-dideoxy-2-enopyranose systems with α-erythro configuration in the unusual 5 75, 76 Better overall yields of glycosyl cyanides could be obtained by exchange of the anomeric O-acyl group with the cyanide of trimethylsilyl cyanide (TMS-CN) in the presence of BF 3 -OEt 2 in nitromethane. [77] [78] [79] [80] Thus, per-O-acetyl-α/β-D-galactopyranoses could be directly converted into per-O-acetyl-β-D-galactopyranosyl cyanide. But, BF 3 -OEt 2 is hazardous, unstable, and harsh, and significant decomposition and incompatibility with glycosidic bonds were observed. However, the elimination of the unstable glycosyl bromides as intermediates was a distinct advantage. We decided to investigate the use of HgBr 2 , as a milder catalyst for this reaction (Schemes 4,5). 
81-83
When per-O-acetyl-α-or β-D-glucopyranose was treated with excess TMS-CN and 0.1 molar equiv of HgBr 2 in nitromethane for 2 days in the absence of Hg(CN) 2 , the major product was the 1,2-cyanoethylidene derivative 36 in 59% yield, along with only 5% of the preferred cyanide 37, and about 28% of starting material (Scheme 4), [81] [82] [83] We could use this reagent not only to convert O-glycosidic glycals into 2,3-eno-pyranosyl cyanides (Scheme 6) but also to obtain anomeric cyanides from glycal dimers and tetramers (Scheme 7) which are 2-C-2-deoxy-sugars. [62] [63] [64] 92 The reagent was compatible with 1,4-and 1,6-O-glycosidic linkages, which are normally prone to cleavage in the presence of BF 3 .
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The reagent Hg(CN) 2 , HgBr 2 and TMSCN, applied to compound 31, replaced the anomeric acetate group in ring A, to give the expected glycosyl cyanide 45 (Scheme 7). [62] [63] [64] However, compound 33 (a dimer from tri-O-acetyl-L-fucal) gave unexpectedly the doubly unsaturated cyanide 47 (Scheme 7). [62] [63] [64] 92 Similarly, the galactal dimer 32 gave a doubly unsaturated cyanide
46.
Although the dimers 32 and 33 had only a stereochemical difference with 31 in the relative disposition of the 4-acetoxy group, the substitution of the anomeric acetoxy group was attended by elimination of AcOH, with deprotonation at C-2. [62] [63] [64] 92 A relief of steric strain may be a driving force for this elimination. Indeed, the molecular mechanics calculations (MM+) revealed a substantially higher steric strain (by 3-4 kcal/mol) in the most stable conformation of 33 when compared with 6A,6B-dideoxy analog of 31, which is a stereoisomer of 33. From the Boc-protected aminomethyl-C-fucopyranoside synthons, a great variety of biologically interesting glycoconjugates are accessible. Transformation of the 1° amino functionality into an isocyanate allows coupling with the former 1° amine or the 2° amine dimer. Other nucleophiles would give glycoconjugates with minimal scaffolding such as unsymmetrical ureas. This could be accomplished in many ways, but most commonly by phosgenation, 99 which is economical and practical, since the advent of crystalline "triphosgene". We removed the Boc-protective group from the aminomethyl-C-monosaccharide 53 with TosOH-H 2 O in CH 2 Cl 2 , and the resultant salt, in solution, was directly converted with 1/6 equivalents of triphosgene in a CH 2 Cl 2 -saturated sodium bicarbonate two-phase system (Scheme 8), via the in situ amino-and isocyanato-monosaccharide intermediates, into the novel di-fucopyranosyl methyl-substituted urea 55 in 63% yield, along with 49 (12%) through O-N-acetyl migration. 81, 82, [94] [95] [96] When the same deprotection and two-phase phosgenation was applied to the N-linked disaccharide 54, a novel tetra-fucopyranosyl methyl-substituted urea 57 (28%) was obtained along with the O-N-acetyl migratory side-product 50 (48%) and the stable crystalline carbamoyl chloride 56 (15%; Scheme 8) -a potentially useful reactant for preparation of more complex Cglycosidic conjugates. The yield for the tetra-substituted urea derivative was surprisingly high for a bimolecular reaction of two sterically hindered intermediates, which had to compete with the major intramolecular pathway of acetyl migration, after Boc removal. Formation of acetyl migratory side products 49 and 50 was increased if a weaker acid such as trifluoroacetic acid was employed to remove the Boc-protective group, or if Hűnig's base was used in a single non-polar organic solvent instead of a two-phase system with aqueous bicarbonate. With an excess (1/3 equivalents) of triphosgene, acetyl migratory product was minimized, and formation of the tetrasubstituted urea also ceased, but the yield of the interesting carbamoyl chloride 56 increased to 67%. It was successfully isolated by column chromatography on normal SiO 2 , by elution with isopropyl ether. Scheme 8 summarizes the synthetic possibilities for the two readily obtainable Boc-aminomethyl saccharides 53 and 54. The utility of compounds 53, 54, and 56 is readily appreciated, for attaching stable β-L-fucopyranosyl residues via amide, urethane, or urea bonds to carboxyl, hydroxyl, or amino groups of proteins or other biological scaffolds, to produce e.g. "neoglycoproteins." This methodology should be extendable to other sugars.
We have shown that O-acetyl protective groups are removable under very mild conditions, with NEt 3 /MeOH/H 2 O. 100 The base and the byproduct AcOH are smoothly removed by azeotropic water vapor distillation in vacuo, or presumably also by freeze drying, without damage to delicate biochemical substrates.
Henry Condensation
One of the most common methods for the chain extension of carbohydrates is the Henry condensation of pentoses and hexoses with nitromethane in the presence of a strong base. Scheme 9. Henry condensation of protected and unprotected β-D-glucopyranose.
82,104-107
We had synthesized 82, [104] [105] [106] [107] directly the cyclic compounds in aprotic solvents with a highly active bifunctional 108 catalyst 2-hydroxypyridine 109 and DBU/molecular sieves 104 with an improved yield of 77%. 105 We avoided protic solvents because of the strong basicity of DBU, which would provide just another way of creating RO -in ROH. The cyclic product 63 was produced in a single step along with two minor byproducts 60 and 64. 104 We reinvestigated later 82,106,107 our original condensation 104, 105 of nitromethane with 4,6-O-benzylidene-D-glucopyranose 59 to nitromethyl 4,6-O-benzylidene β-D-glucopyranoside 63 and discovered that 2-HP was unnecessary. A time study, with careful TLC analysis and flash chromatography of the reaction mixture with DBU and molecular sieves revealed sequential products, which are conveniently explained as outlined in the mechanistically simplified Scheme 9.
The condensation progressed similarly in THF and dioxane, with 4,6-O-benzylidene-D-glucopyranose via 5,7-O-benzylidene-1-deoxy-1-nitro-D-glycero-D-gulo-heptitol 60, which subsequently changed into nitromethyl β-D-glucopyranoside 63. The former was observed accumulating before being further converted during at least 50 hours at room temperature to the cyclic product 63, along with some 5,7-O-benzylidene-1,2-dideoxy-1-nitro-2-nitromethyl-D-gluco-heptitol 64, in yields similar to those already reported. 104, 105 In THF or dioxane, accumulation of the final acyclic product 64 was dependent on temperature, time, and solvent: less decomposition was observed in dioxane. In these condensations, we could not determine if the presence of 2-HP had any effect at all, at any stage of the reaction. In any case, the first heptitol 60 and the desired 63 were kinetically controlled intermediates, which, given enough time, were transformed into the "thermodynamic" product 64, by a still slower overall rate. When similar conditions were employed for unprotected D-glucose 58, there was no reaction for prolonged periods of time. Heating only resulted in almost complete decomposition. This was expected since unprotected sugars are typically not very soluble in THF or dioxane. But in acetonitrile, pyridine or a mixture of these at 50 °C, the condensations were fairly clean. 82, 106, 107 The condensation progressed to completion within one day, and only nitromethyl β-Dglucopyranoside 62 (Scheme 9) was detected and isolated when 5:1 acetonitrile/pyridine (38% yield) or pyridine was used as the solvent (57% yield). For completion and maximal yield, a stoichiometric amount of DBU was needed.
Condensations with L-fucose 65 were monitored by TLC and flash chromatography, and gave sequential products as outlined in Scheme 10. 82, 106, 107 Within 12 h in THF more than half of the starting L-fucose was converted into corresponding 1,6-dideoxy-1-nitro-L-glycero-D-mannoheptitol 66. By the end of day 3, most of L-fucose had been transformed into the acyclic heptitol 66, and the subsequent conversion into cyclic nitromethyl β-L-fucopyranoside 67 was followed for another 5 days, during which time a significant portion of the desired cyclic product 67 had also been slowly converted into 1,1,6-trideoxy-1-nitro-2-nitromethyl-L-galacto-heptitol 68. Thus, the maximal yield for product 67 required minimizing decomposition and the yields of 66 and 68. In dioxane, only 67 was isolated as the product (62% A possible further transformation of the synthesized nitro-compounds is illustrated by the reduction of nitromethyl β-D-glucopyranoside 63 with a specially prepared elemental iron in water/THF under CO 2 atmosphere to aminomethyl-C-glucopyranoside 69 (Scheme 11). 104 Scheme 11. Reduction of the Henry condensation product 63 to the aminomethyl-C-glycoside 69.
Condensation with Malononitrile
As described above, Henry condensation with nitromethane of partially protected and nonprotected pyranoses with a free anomeric hemiacetal function in presence of DBU and molecular sieves produces C-glycosides, which molecules incorporated one or two molecules of nitromethane (an example of L-fucose reaction is shown on Scheme 10). The ratio of products substantially depended on conditions of the reaction. 82, [104] [105] [106] [107] Inspired by this result, we explored a possibility of a similar synthesis of C-glycosides using malononitrile (MN) instead of nitromethane as an active methylene component (Scheme 12). 110, 111 Malononitrile is a versatile compound of exceptional reactivity. 112, 113 It is often used as a reactant for synthesis of heterocycles since the methylene group and either one or both cyano groups can take part in condensation reactions to give a variety of addition products and heterocyclic compounds. [114] [115] [116] MN has not been used for preparation of C-glycosides, though their formation using dialkyl malonates was studied extensively. L-Fucose 65 was selected as a starting carbohydrate. We expected products similar to those obtained in reaction with nitromethane (Scheme 10). However, the reaction was much faster (1 h instead of several days), and neither mono-adduct 70 nor bis-adduct 71 (Scheme 12), which are analogs of 67 and 68 (Scheme 10), was obtained. Instead, two cyclic compounds 73 (oil) and 74 (white crystals) in a ratio ~5:1 (by NMR) were isolated by a column chromatography of the reaction mixture (Scheme 13). The bicyclic structure 74 was proven by X-ray crystallography ( Figure 6 ). 110, 118 Interestingly, the solution conformation (in CD 3 OD) of the side chain in 74 estimated from the vicinal spin-spin couplings in 1 H NMR correlated well with the crystal structure data. 111 To the best of our knowledge, no compounds have been described so far with this combination of fiveand six-membered oxygen-containing heterocycles. 
110,118
The results of the synthesis may be rationalized as a sequence of (a) Knoevenagel condensation producing intermediate 72, then (b) Michael addition of another MN resulting in formation of bis-adduct 71, and then (c) a base-induced double cyclization. The latter can occur via either the dihydrofuran derivative 73, or the dihydropyran derivative 73a. However, we isolated only one monocyclic compound, which structure could not be assigned based on NMR data. In an attempt to prepare a crystalline derivative appropriate for X-ray analysis, we acetylated product 73 (Scheme 14) and obtained the furan derivative 75, which NMR parameters perfectly matched the parameters of similar furan derivatives described in literature. 119 
Total Syntheses of Aminomethyl-C-dideoxyglycopyranosides and their Quinamides
The great majority of methods developed for the synthesis of C-glycosides [18] [19] [20] 121 We developed an approach to the total syntheses of partially functionalized β-Cglycopyranosides, 49, 93, [122] [123] [124] [125] [126] [127] [128] related to 2,4-and 4,6-dideoxyhexoses, found as cardiac glycosides. 129, 130 These C-glycosides are tetrahydropyrans obtained from homoallylic alcohols and acetals by a Lewis acid promoted cyclization, followed by dehydrohalogenation and subsequent double bond functionalization. 49, 93, [122] [123] [124] [125] [126] [127] [128] A subsequent use of these building blocks for the syntheses of di-and oligosaccharide mimics is illustrated by their quinoylation. Quinic acid is an important structural component in a number of naturally occurring biologically active compounds which exhibit HIV-integrase inhibition, [131] [132] [133] as well as hypocholesterolemic, 134 hepatoprotective 135 and antioxidative [136] [137] [138] activities. A combination of racemic aminomethyl Cglycosides with chiral quinic acid may directly yield biologically active chiral compounds. Acid catalyzed reactions between homoallylic alcohols and aldehydes or acetals have been used before for the preparation of 2,6-disubstituted di-and tetrahydropyran derivatives (see Ref. 92 and references therein). We chose an expandable two-component scheme of cyclization with a possibility of various functional groups in readily available starting compounds. Use of phthalimido derivatives allowed for syntheses of (protected) aminomethyl C-glycopyranosides (Scheme 15).
Cyclizations of this type furnish exclusively cis-2,6-disubstituted tetrahydropyrans 49, 93, [122] [123] [124] [125] [126] [127] [128] corresponding to the β-configuration of the projected C-glycopyranosides. Most C-glycoside syntheses provide α-products. 19, 20 The new stereocenter C(6) is entirely determined by the configuration of the existing stereocenter in the homoallylic alcohol. Chiral homoallylic alcohols would give enantiomerically pure tetrahydropyrans, and finally C-glycosides. We obtained racemic aminomethyl C-glycosides, subsequently acylated with the chiral lactone of quinic acid 11 (Scheme 15), and separated as derivatives of diastereomeric quinamides (Scheme 16). 49, 128 Specifically for the synthesis of various homoallylic alcohols (Scheme 15), we developed new methods: transallylation 139 
C-Glycosides via Cycloadditions
The aqueous hetero-Diels-Alder reaction has been investigated by A. Lubineau et. al., [147] [148] [149] [150] [151] for the synthesis of dihydropyran cyclo-adducts. We wanted to explore their use, through dihydroxylation of the double bond for syntheses of C-glycosides, 152, 153 The cis-isomer 111 gave only one major racemic product of cis-dihydroxylation (112). It is not clear why the molecule 111 does not allow OsO 4 approach from both sides. Similarly, the epoxidation of 111 gave a crude epoxide 113 (Scheme 17) in 84% yield, the NMR and TLC of which showed no evidence of the epoxide with opposite configuration. Its purification by column chromatography proved to be difficult, due to its instability. As expected, acid hydrolysis (113→114) gave a single major product, which could be isolated pure after esterification to 115 (81% overall; Scheme 17). It is advantageous, that any "opposite epoxide" in the crude mixture also would give preferentially the same diaxial hydrolysis product 114. 143 cis-Dihydroxylation of trans-isomer 110 gave a mixture of stereoisomeric 116 and 117 (ratio 3:1 by NMR; overall yield 73%). Compound 116 was crystallized from the mixture (57%). Compound 117 was not successfully isolated from the mother liquor, but its 1 H-NMR parameters were determined from the mixture. The epoxidation of trans-ester 110 gave two epoxides 118 and 119 as detected by TLC. Their mixture was subjected to hydrolysis and methylation to give a mixture of trans-dihydroxy esters 120 and 121, which was separated by column chromatography (yields 38% and 43% respectively).
We also tried to separate the carboxylic acids 108 and 109 by the reaction of NBS with their mixture. Only the trans-isomer 108 reacted with NBS to form a bromolactone, and the lactone 122 was easily separated from the reaction mixture, but the yield was too low (15-25%). The nature of the side reaction of the trans-isomer with NBS could not be determined. The bromolactone 122 was cleaved by NaOMe to give the single epoxide 118 which was hydrolyzed to give a single carboxylic acid 120, providing another structure proof for it (Scheme 17).
Thus, the hetero-Diels-Alder reaction between inexpensive 50% aq. glyoxylic acid and technical grade piperylene provided a starting point for synthesis of a series of 2,6-anhydro-2,4,5,6-tetrahydroxy-D,L-heptanoic acid esters, 152, 153 which are C-glycosidic analogs of 2,6-dideoxypyranoses, prominent in cardiac glycosides. 154 When racemate 112 and 4,6-O-benzylidene-β-D-glucopyranosyl methylamine 99 104 were refluxed in methanol in presence of a catalytic amount of NaOMe, the reaction was completed in 3 hours, and produced the amide 100 (87%) as a mixture of diastereomers (Scheme 18). Such conjugates with natural carbohydrate derivatives offer potential for chiral resolution. Glycobiological applications for these compounds appear very possible. membered cyclic compounds may be considered as monosaccharide structural analogs, and thus potential inhibitors of glycosidases. In a search for simple, readily accessible, but efficient glycosidase inhibitors, we designed, prepared, and assayed a series of cyclohexanecarboxylic acids and esters of types 125-131 with different substitution pattern, configuration, and length of n-alkyl groups R, in order to reveal the effects of these parameters upon the inhibitory activity ( Figure 7) . 
111,155-158
The proposed structures contained a six-membered cycle and several hydrophilic groups, which is typical for many carbohydrate mimetics (see above). Alkyl groups were introduced to enhance the inhibiton. Such effect of lipophilic groups was observed previously [18] [19] [20] [21] [22] [23] for derivatives of 1-deoxynojirimycin and other iminosugars, alkyl glycosides, and some other glycosidase inhibitors. The preliminary tests against fungal glycosidases revealed only a weak to moderate inhibition of β-D-glucosidase by compounds 125 (R = H) and 127+128 (R = CH 3 , n-C 6 H 13 ), and a weak inhibition of α-L-fucosidase by compounds 125+126, and 127+128 (R = CH 3 , n-C 6 H 13 ). 111, 155, 156 However, very promising results were obtained for cyclohexanedicarboxylic acids of types 129-131. 111, [155] [156] [157] [158] The synthesis of compounds 129-131
is presented in Scheme 19. It employed very simple starting compounds and reagents, and rather standard synthetic procedures. These diacids were assayed for inhibitory activity against several glycosidases in multienzyme complexes isolated from fungi Penicillium canescens and Aspergillus oryzae. 111, [155] [156] [157] [158] The inhibition was found to be specific with regard to the configuration of inhibitor, the type of enzyme, and even the particular source of enzyme. Most noticeably, these compounds inhibited α-and β-D-glucosidases. The isomers 130 and 131 appeared to be more selective inhibitors. It is worth mentioning that the compound 129e produced the same inhibition effect upon β-D-glucosidase from A. oryzae, as a ~10-fold higher concentration of methyldeoxynojirimycin.
The results of our studies proved that simple and readily available racemic derivatives of 1,2-cyclohexanedicarboxylic acid can be potent inhibitors for α-and β-D-glucosidases The presence of at least two carboxylic groups and one hydroxy group was found to be essential for efficient inhibition. Its magnitude depended on configuration of substituents and increased for β-glucosidase with lengthening of the inhibitor's alkoxy group. Further studies towards the enhancement of inhibitory activity may be focused on separation of enantiomers, on variation of the substituent configuration, of the length and structure of the lipophilic groups, and of the nature of heteroatoms. These compounds may be considered as promising precursors for combination with natural fragments (e. g. shikimic acid; see Sections 2, 7) for the synthesis of diastereomeric SCOMs.
